Compare IDYA & AAUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDYA | AAUC |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | 2019 | N/A |
| Metric | IDYA | AAUC |
|---|---|---|
| Price | $34.38 | $23.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $49.18 | N/A |
| AVG Volume (30 Days) | ★ 943.7K | 724.2K |
| Earning Date | 02-12-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $214,834,000.00 | ★ $1,074,850,000.00 |
| Revenue This Year | $2,662.86 | $80.45 |
| Revenue Next Year | N/A | $54.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5377.66 | 45.41 |
| 52 Week Low | $13.45 | $6.84 |
| 52 Week High | $37.08 | $25.10 |
| Indicator | IDYA | AAUC |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 58.38 |
| Support Level | $33.11 | $22.95 |
| Resistance Level | $34.45 | $24.99 |
| Average True Range (ATR) | 1.14 | 0.90 |
| MACD | -0.08 | -0.13 |
| Stochastic Oscillator | 44.14 | 55.54 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, the development of new mines, the advancement of its exploration properties, and, targeting other consolidation opportunities with a focus on Africa.